| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.062 | 0.3 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |